| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David Henry MacK | President and CEO | 2025-10-27 | 220,643 | $1.37 | $302.28kBuy |
| Orbimed Advisors LLC | 10% Owner | 2025-10-23 | 1,000,000 | $1.52 | $1.52MSell |
| Orbimed Advisors LLC | 10% Owner | 2025-09-10 | 500,000 | $1.80 | $900.00kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Arnold L. Oronsky | 12.13% | 6,469,911 | $8.15M | Insider |
| Orbimed Advisors LLC | 9.54% | 5,089,330 | $6.41M | Insider |
| Interwest Partners X LP | 8.44% | 4,502,480 | $5.67M | Insider |
| V. Oncology Scs Sicavsif Nextech | 4.74% | 2,528,290 | $3.19M | Insider |
| Boxer Capital LLC | 4.37% | 2,329,073 | $2.93M | Insider |
| Ra Capital Management LP | 3.21% | 1,710,265 | $2.15M | Insider |
| Thilo Schroeder | 2.06% | 1,101,283 | $1.39M | Insider |
| Wellington Biomedical Innovation Master Investors Cayman I LP | 1.43% | 760,267 | $957.94k | Insider |
| David Henry MacK | 0.95% | 508,087 | $640.19k | Insider |
| Arnold J. Levine | 0.77% | 409,842 | $516.40k | Insider |